RiverGlade taps Hudak as operating partner


RiverGlade Capital, a healthcare services-focused private equity firm, has named Jim Hudak as an operating partner. Previously, Hudak was CEO of Paradigm Outcomes.

PRESS RELEASE

CHICAGO (PRWEB) AUGUST 09, 2018

RiverGlade Capital (“RiverGlade”), is pleased to announce that Jim Hudak has been engaged as an Operating Partner and will have an exclusive relationship with the firm. As an Operating Partner, Mr. Hudak will play a key role in the firm’s strategic planning, human capital sourcing, and deal origination, evaluation and diligence. He brings a wealth of healthcare industry knowledge and executive operating experience to RiverGlade, having spent the last six years as Chief Executive Officer of Paradigm Outcomes before moving into the Executive Chairman role in late 2017. Prior to Paradigm, Mr. Hudak was Chief Administrative Officer at CRC Health Group, where he oversaw several functions including human resources, IT, risk management and finance and spent a number of years at Accenture (formerly Andersen Consulting), ultimately becoming the Global Managing Partner of the Healthcare Practice. Additionally, he was Executive Vice President of UnitedHealth Group and Corporate Chief Information Officer and Chief Executive Officer of its subsidiary United Behavioral Health.

Mr. Hudak received his Bachelor’s in economics at Yale University and a Master’s of Public Policy from the Gerald R. Ford School of Public Policy (the “Ford School”) at the University of Michigan. Mr. Hudak also chairs the Ford School Committee, which provides volunteer leadership in fundraising and reviews the goals, programs and plans of the school.

The RiverGlade investment team has added Dan Skowronski as Vice President. Mr. Skowronski has eight years of experience investing in and advising middle market companies. Prior to joining RiverGlade, Mr. Skowronski was a Senior Associate at The Edgewater Funds and prior to that was an Associate at Swander Pace Capital.

During his time at Edgewater and Swander Pace, Mr. Skowronski was involved in all aspects of each firm’s investment process including deal origination and execution, debt financing and refinancing transactions, portfolio company sales, add-on acquisitions, and restructurings, as well as monitoring of portfolio companies in the healthcare, consumer and industrials sectors. Previously, he was an Investment Banking Analyst at William Blair & Company, where he executed sell-side and buy-side transactions for private equity firms, publicly-traded companies and privately-held and family-owned businesses in the consumer & retail sector. Mr. Skowronski began his career as a Financial Advisory Services Analyst at Houlihan Lokey, where he provided fairness opinions, solvency opinions and valuations for privately-held and publicly-traded companies across a variety of industries. Mr. Skowronski holds a BBA in Finance from University of Michigan’s Ross School of Business and an MBA from Northwestern University’s Kellogg School of Management.

About RiverGlade Capital
RiverGlade Capital is a healthcare services focused private equity firm that targets founder-owned, high-quality, differentiated businesses. RiverGlade partners with companies that have proven historical organic growth where value can be accelerated through human capital investments, operational improvements, strategic planning, and dynamic organic and inorganic growth initiatives. For more information, visit http://www.rivergladecapital.com.

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.